Related Experiment Video
Updated: Jun 27, 2025
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Estimating Gestational Age and Prediction of Preterm Birth Using Metabolomics Biomarkers
Victoria C Ward1, Steven Hawken2, Pranesh Chakraborty3
1Department of Pediatrics, Stanford University School of Medicine, 291 Campus Drive Li Ka Shing Building, Stanford, CA 94305, USA.
Insights
Preterm birth (PTB) is a major global health issue, particularly in low-resource areas. Metabolomics biomarkers show promise for identifying high-risk pregnancies and estimating gestational age and preterm status.
Area of Science:
- Biomedical research
- Public health
- Metabolomics
Background:
- Preterm birth (PTB) is a significant cause of child mortality worldwide.
- Accurate gestational age (GA) assessment is challenging in low-resource settings, hindering PTB burden measurement.
- First trimester ultrasound dating is the gold standard for GA estimation.
Purpose of the Study:
- To explore the potential of metabolomics biomarkers for PTB research.
- To investigate biomarkers for early identification of high-risk pregnancies.
- To assess biomarkers for estimating GA and postnatal preterm status.
Main Methods:
- Utilizing metabolomics to analyze biological samples.
- Developing and validating biomarker panels.
- Comparing biomarker-based GA estimation with traditional methods.
Main Results:
- Metabolomics biomarkers demonstrate potential for GA estimation.
- Biomarkers may aid in identifying pregnancies at risk for PTB.
- Further research is needed to validate these findings in diverse populations.
Conclusions:
- Metabolomics offers a novel approach to address PTB challenges.
- Biomarkers could improve PTB surveillance and risk assessment globally.
- This research highlights the need for biomarker-driven solutions in maternal and child health.
Abstract:
Preterm birth (PTB) is a leading cause of morbidity and mortality in children aged under 5 years globally, especially in low-resource settings. It remains a challenge in many low-income and middle-income countries to accurately measure the true burden of PTB due to limited availability of accurate measures of gestational age (GA), first trimester ultrasound dating being the gold standard. Metabolomics biomarkers are a promising area of research that could provide tools for both early identification of high-risk pregnancies and for the estimation of GA and preterm status of newborns postnatally.
